Lithera Announces Company Name Change to Neothetics, Inc.
August 12, 2014 07:00 ET
|
Neothetics
SAN DIEGO, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc., announced today that it has changed its name to Neothetics, Inc. The new name strengthens the company's positioning as a clinical-stage,...
Lithera to Present at the 13th Annual Needham Healthcare Conference
April 02, 2014 07:00 ET
|
Neothetics
SAN DIEGO, April 2, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
Lithera to Present at Cowen and Company Health Care Conference
February 27, 2014 07:00 ET
|
Neothetics
SAN DIEGO, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
Lithera Announces Final Closing of $35.6 Million Series C Financing
February 11, 2014 07:00 ET
|
Neothetics
SAN DIEGO, Feb. 11, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer
November 21, 2013 07:00 ET
|
Neothetics
SAN DIEGO, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, today...
Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring
September 30, 2013 07:00 ET
|
Neothetics
SAN DIEGO, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, today...
Lithera Announces Second Closing of $27.3 Million Series C Financing
July 18, 2013 07:00 ET
|
Neothetics
SAN DIEGO, July 18, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on aesthetic and medical indications, today announced that it...
Lithera Announces Notice of Allowance for Key United States Patent Application for LIPO-202, Its Novel Product for Localized Fat Reduction
January 07, 2013 09:00 ET
|
Neothetics
SAN DIEGO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering formulations and...
Lithera, Inc. Completes $20.6 Million Equity Financing
December 19, 2012 09:00 ET
|
Neothetics
SAN DIEGO, Dec. 19, 2012 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced investment of $20.6 million in preferred stock equity financing. Additional investment may provide the Company with up to a...
Lithera, Inc. Appoints Thomas Wiggans to Board of Directors
April 04, 2011 09:00 ET
|
Neothetics
SAN DIEGO, April 4, 2011 (GLOBE NEWSWIRE) -- Lithera, Inc. announced today the appointment of Thomas G. Wiggans to its Board of Directors.
"Lithera is making substantial progress with LIPO-102 by...